DocSym
β
Searchsearch
Search
(A30.5) Lepromatous leprosy
More details coming soon
622 in individuals diagnosis lepromatous leprosy confirmed
Diagnosis lepromatous leprosy is diagnosed Men are 5.79% more likely than Women
329
Men receive the diagnosis lepromatous leprosy
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
293
Women receive the diagnosis lepromatous leprosy
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease lepromatous leprosy - Men aged 25-29 and Women aged 90-94
In Men diagnosis is most often set at age 25-29
Less common in men the disease occurs at Age 0-24, 30-95+Less common in women the disease occurs at Age 0-89, 95+
In Women diagnosis is most often set at age 90-94
Disease Features lepromatous leprosy
Absence or low individual and public risk
Lepromatous leprosy - what does this mean
Lepromatous leprosy is an infectious disease caused by the bacterium mycobacterium leprae. it is characterized by the formation of nodules or bumps on the skin, which can lead to permanent deformity of the hands, feet, and face. this form of leprosy is highly contagious and is spread through contact with the skin lesions of an infected person.
What happens during the disease - lepromatous leprosy
Lepromatous leprosy is caused by the mycobacterium leprae bacterium, which enters the body through the mucous membranes or through broken skin. once inside the body, the bacteria multiplies and spreads through the blood and lymphatic system, leading to damaged nerves, skin lesions, and disfigurement. the body's immune system is unable to fight off the bacteria, allowing it to cause further damage to the skin, eyes, and other organs.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Clinical examination
- Skin biopsy
- Blood tests for antibodies
- X-ray of the skull and other bones
- Nerve conduction studies
- CT scan of the head
- MRI of the head
- Tissue culture
- Bacterial identification
- Immunofluorescence
Treatment and Medical Assistance
Main Goal: To reduce the risk of complications and disability caused by lepromatous leprosy.
- Administering multi-drug therapy (MDT) to reduce the number of bacteria in the body.
- Providing physical therapy to help preserve muscle strength and mobility.
- Prescribing anti-inflammatory medications to reduce inflammation and pain.
- Encouraging proper nutrition and lifestyle changes.
- Administering immunization against tuberculosis to prevent secondary infections.
- Providing psychological support to help patients cope with the physical and emotional effects of the disease.
- Recommending surgery to correct deformities caused by the disease.
19 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Lepromatous leprosy - Prevention
The best way to prevent lepromatous leprosy is to practice good personal hygiene, such as washing hands frequently and avoiding contact with those who are infected. vaccinations are also available in some countries to help protect against the disease. additionally, early diagnosis and prompt treatment are essential in controlling and preventing the spread of lepromatous leprosy.